Clinical Research
BibTex RIS Cite

Year 2023, Volume: 4 Issue: 2, 70 - 77, 31.05.2023

Mehmet Yıldız Halit Fidancı Gülçin Ortaç Şencan Buturak Zülfikar Arlıer

https://doi.org/10.47482/acmr.1170798

Abstract

References

  • Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397(10280):1214-28.
  • Harutoshi F. The Guillain-Barré syndrome. Handb Clin Neurol. 2013;115:383-402.
  • Rajabally Y, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115-9.
  • Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry. 2010;81(10):1157-63.
  • Uncini A, Ippoliti L, Shahrizaila N, Sekiguchi Y, Kuwabara S. Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis. Clin Neurophysiol. 2017;128(7):1176-83.
  • Cornblath DR, Mellits ED, Griffin JW, McKhann GM, Albers JW, Miller JW, et al. Motor conduction studies in Guillain–Barré syndrome: description and prognostic value. Ann Neurol. 1988;23(4):354-9.
  • Hiraga A, Mori M, Ogawara K, Kojima S, Kanesaka T, Misawa S, et al. Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 2005;76(5):719-22.
  • Willison HJ, Jacobs BC, van Doorn P. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–27.
  • Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory neuropathy share a common immunological profile. J Neurol Sci. 1999;168(2):121-6.
  • Alberti MA, Alentorn A, Martinez-Yelamos S, Martínez-Matos J, Povedano M, Montero J, et al. Very early electrodiagnostic findings in Guillain-Barre syndrome. J Peripher Nerv Syst. 2011;16(2):136-42.
  • Hiew FL, Rajabally YA. Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions. Clin Neurophysiol. 2016;127(2):1683-8.
  • Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):913-7.
  • Umapathi T, Li Z, Verma K, Yuki N. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome. Clin Neurophysiol. 2015;126(12):2376-80.
  • Kleyweg R, van der Meché F, Schimtz P. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14(11):1103-9.
  • Chen S, Andary M, Buschbacher R, Del toro D, Smith B, So Y, et al. Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations. Muscle Nerve. 2016;54(3):371-7. Fidancı H, Öztürk İ, Köylüoğlu AC, Yıldız M, Buturak Ş, Arlıer Z. The needle electromyography findings in the neurophysiological classification of ulnar neuropathy at the elbow. Turk J Med Sci. 2020;50(4): 804-10.
  • Fidancı H, Öztürk İ, Köylüoğlu AC, Yıldız M, Arlıer Z. Bilateral Nerve Conduction Studies Must be Considered in the Diagnosis of Sciatic Nerve Injury Due to Intramuscular Injection. Neurol Sci Neurophysiol. 2020;37(2): 94-9.
  • Uncini A, Susuki K, Yuki N. Nodo-paranodopathies: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol. 2013;124(10):1928-34.
  • Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute demyelinating polyradiculoneuropathy. Clin Neurophysiol. 2004;115(10):2329-35.
  • Chan YC, Punzalan-Sotelo AM, Kannan TA, Shahrizaila N, Umapathi T, Goh EJH, et al. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome. Muscle Nerve. 2017;56(5):919-24.
  • Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998;44(2):202-8.
  • Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020;19(5):383-38.
  • Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6.
  • Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, et al. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain. 2021;144(11):3392-404.

Comparison of ulnar, median, and sural sensory nerve conduction studies between demyelinating and axonal forms of Guillain-Barré Syndrome

Year 2023, Volume: 4 Issue: 2, 70 - 77, 31.05.2023

Mehmet Yıldız Halit Fidancı Gülçin Ortaç Şencan Buturak Zülfikar Arlıer

https://doi.org/10.47482/acmr.1170798

Abstract

Background: Guillain-Barré syndrome (GBS) is an important neurological disease that can cause disability. Axonal GBS and acute inflammatory demyelinating polyradiculoneuropathy (AIDP) are two important subgroups.
Methods: Patients with clinical and electrodiagnostic features compatible with GBS were included in this retrospective study. The patients were divided into two groups neurophysiologically as Axonal GBS and AIDP. Medical research council (MRC) scores of the patients' muscles, median / ulnar / posterior tibial / peroneal / sural nerve conduction study findings were included in the analyses. Sural sparing pattern was considered as the absence of median/ulnar compound nerve action potential (CNAP) and present sural nerve CNAP (SS-M/SS-U).
Results: Twelve AIDP and 10 Axonal GBS patients were included in the study. MRC scores were not different between the two groups (p=0.895). CNAPs of the right median and ulnar nerves were smaller in AIDP patients than in Axonal GBS patients (p<0.001, p=0.004). CNAPs of the right and left sural nerves were not different between the two groups (p=0.140, p=0.099). SS-M / SS-U was observed in 1(10%)/1(10%) and 6(50%)/4(33%) of axonal GBS and AIDP patients, respectively (p=0.074 for SS-M, p =0.323 for SS-U). There was a positive correlation between right median / ulnar nerve CNAP amplitudes and sural nerve CNAP amplitude (p=0.003 r=0.623 / p<0.001 r=0.850).
Conclusion: This study showed that the sural nerve conduction study findings may not be different in axonal GBS and AIDP patients. There may be a relationship between CNAPs of median/ulnar nerves and CNAPs of sural nerves.

Keywords

Acute inflammatory demyelinating polyradiculoneuropathy Guillain-Barré syndrome Sensory nerve conduction study Sural sparing

References

  • Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397(10280):1214-28.
  • Harutoshi F. The Guillain-Barré syndrome. Handb Clin Neurol. 2013;115:383-402.
  • Rajabally Y, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115-9.
  • Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry. 2010;81(10):1157-63.
  • Uncini A, Ippoliti L, Shahrizaila N, Sekiguchi Y, Kuwabara S. Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis. Clin Neurophysiol. 2017;128(7):1176-83.
  • Cornblath DR, Mellits ED, Griffin JW, McKhann GM, Albers JW, Miller JW, et al. Motor conduction studies in Guillain–Barré syndrome: description and prognostic value. Ann Neurol. 1988;23(4):354-9.
  • Hiraga A, Mori M, Ogawara K, Kojima S, Kanesaka T, Misawa S, et al. Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry. 2005;76(5):719-22.
  • Willison HJ, Jacobs BC, van Doorn P. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–27.
  • Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory neuropathy share a common immunological profile. J Neurol Sci. 1999;168(2):121-6.
  • Alberti MA, Alentorn A, Martinez-Yelamos S, Martínez-Matos J, Povedano M, Montero J, et al. Very early electrodiagnostic findings in Guillain-Barre syndrome. J Peripher Nerv Syst. 2011;16(2):136-42.
  • Hiew FL, Rajabally YA. Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions. Clin Neurophysiol. 2016;127(2):1683-8.
  • Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):913-7.
  • Umapathi T, Li Z, Verma K, Yuki N. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome. Clin Neurophysiol. 2015;126(12):2376-80.
  • Kleyweg R, van der Meché F, Schimtz P. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14(11):1103-9.
  • Chen S, Andary M, Buschbacher R, Del toro D, Smith B, So Y, et al. Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations. Muscle Nerve. 2016;54(3):371-7. Fidancı H, Öztürk İ, Köylüoğlu AC, Yıldız M, Buturak Ş, Arlıer Z. The needle electromyography findings in the neurophysiological classification of ulnar neuropathy at the elbow. Turk J Med Sci. 2020;50(4): 804-10.
  • Fidancı H, Öztürk İ, Köylüoğlu AC, Yıldız M, Arlıer Z. Bilateral Nerve Conduction Studies Must be Considered in the Diagnosis of Sciatic Nerve Injury Due to Intramuscular Injection. Neurol Sci Neurophysiol. 2020;37(2): 94-9.
  • Uncini A, Susuki K, Yuki N. Nodo-paranodopathies: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol. 2013;124(10):1928-34.
  • Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute demyelinating polyradiculoneuropathy. Clin Neurophysiol. 2004;115(10):2329-35.
  • Chan YC, Punzalan-Sotelo AM, Kannan TA, Shahrizaila N, Umapathi T, Goh EJH, et al. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome. Muscle Nerve. 2017;56(5):919-24.
  • Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998;44(2):202-8.
  • Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020;19(5):383-38.
  • Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6.
  • Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, et al. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain. 2021;144(11):3392-404.
There are 23 citations in total.

Details

Primary Language English
Subjects Neurology and Neuromuscular Diseases
Journal Section ORIGINAL ARTICLE
Authors

Mehmet Yıldız 0000-0002-0411-6794

Halit Fidancı 0000-0001-6573-9090

Gülçin Ortaç 0000-0001-5072-8380

Şencan Buturak 0000-0002-7496-5628

Zülfikar Arlıer 0000-0003-2645-648X

Publication Date May 31, 2023
Submission Date September 4, 2022
Published in Issue Year 2023 Volume: 4 Issue: 2

Cite

APA Yıldız, M., Fidancı, H., Ortaç, G., Buturak, Ş., et al. (2023). Comparison of ulnar, median, and sural sensory nerve conduction studies between demyelinating and axonal forms of Guillain-Barré Syndrome. Archives of Current Medical Research, 4(2), 70-77. https://doi.org/10.47482/acmr.1170798
 Download Cover Image

Archives of Current Medical Research (ACMR) provides instant open access to all content, bearing in mind the fact that presenting research

free to the public supports a greater global exchange of knowledge.

http://www.acmronline.org/